A Phase I Pharmacologic and Pharmacogenetic Trial of Sequential 24-Hour Infusion of Irinotecan Followed by Leucovorin and a 48-Hour Infusion of Fluorouracil in Adult Patients With Solid Tumors

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-04-2439
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

A 24-Hour Continuous Infusion Study of Bivalirudin in the Rat

International Journal of Toxicology
Toxicology
2003English

Increased Tolerability of Bimonthly 12-Hour Timed Flat Infusion 5-Fluorouracil/Irinotecan Regimen in Advanced Colorectal Cancer: A Dose-Finding Study

Oncology Reports
MedicineCancer ResearchOncology
2006English

A Randomized Phase 2 Trial Comparing 3-Hour Versus 96-Hour Infusion Schedules of Paclitaxel for the Treatment of Metastatic Breast Cancer

Cancer
Cancer ResearchOncology
2010English

A Phase II Evaluation of a 3-Hour Infusion of Paclitaxel, Cisplatin, and 5-Fluorouracil in Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck

Cancer
Cancer ResearchOncology
2006English

Safe and Tolerable One-Hour Pamidronate Infusion for Multiple Myeloma Patients

Therapeutics and Clinical Risk Management
2008English

Phase I Trial of Irinotecan, Infusional 5-Fluorouracil, and Leucovorin (FOLFIRI) With Erlotinib (OSI-774): Early Termination Due to Increased Toxicities

Clinical Cancer Research
Cancer ResearchOncology
2004English

A Phase IB Trial of 24-Hour Intravenous PX-12, a Thioredoxin-1 Inhibitor, in Patients With Advanced Gastrointestinal Cancers

Investigational New Drugs
OncologyPharmacology
2012English

Identical 24-Hour Intragastric pH Response to Low Continuous Infusion Doses of Famotidine in Active Gastric Ulcer Patients.

Internal Medicine
Internal MedicineMedicine
1992English

Phase I Trial of Weekly Topotecan and Gemcitabine in Patients With Solid Tumors

American Journal of Clinical Oncology: Cancer Clinical Trials
Cancer ResearchOncology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy